PL3129378T3 - Związki hamujące bromodomenę i zawierająca je kompozycja farmaceutyczna do zapobiegania lub leczenia nowotworu - Google Patents
Związki hamujące bromodomenę i zawierająca je kompozycja farmaceutyczna do zapobiegania lub leczenia nowotworuInfo
- Publication number
- PL3129378T3 PL3129378T3 PL15776821T PL15776821T PL3129378T3 PL 3129378 T3 PL3129378 T3 PL 3129378T3 PL 15776821 T PL15776821 T PL 15776821T PL 15776821 T PL15776821 T PL 15776821T PL 3129378 T3 PL3129378 T3 PL 3129378T3
- Authority
- PL
- Poland
- Prior art keywords
- bromodomain
- cancer
- treating
- preventing
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
- A61K31/5517—1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201461977370P | 2014-04-09 | 2014-04-09 | |
EP15776821.9A EP3129378B1 (en) | 2014-04-09 | 2015-04-08 | Bromodomain-inhibiting compounds and pharmaceutical composition comprising same for preventing or treating a cancer |
PCT/KR2015/003530 WO2015156601A1 (en) | 2014-04-09 | 2015-04-08 | Bromodomain-inhibiting compounds and pharmaceutical composition comprising same for preventing or treating a cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
PL3129378T3 true PL3129378T3 (pl) | 2020-03-31 |
Family
ID=54288110
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL15776821T PL3129378T3 (pl) | 2014-04-09 | 2015-04-08 | Związki hamujące bromodomenę i zawierająca je kompozycja farmaceutyczna do zapobiegania lub leczenia nowotworu |
Country Status (9)
Country | Link |
---|---|
US (1) | US9884874B2 (pl) |
EP (1) | EP3129378B1 (pl) |
JP (1) | JP6333996B2 (pl) |
KR (1) | KR101928521B1 (pl) |
CN (1) | CN106132968B (pl) |
DK (1) | DK3129378T3 (pl) |
ES (1) | ES2751642T3 (pl) |
PL (1) | PL3129378T3 (pl) |
WO (1) | WO2015156601A1 (pl) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3454862A4 (en) | 2016-05-10 | 2020-02-12 | C4 Therapeutics, Inc. | SPIROCYCLIC DEGRONIMERS FOR TARGET PROTEIN REDUCTION |
CN109641874A (zh) | 2016-05-10 | 2019-04-16 | C4医药公司 | 用于靶蛋白降解的c3-碳连接的戊二酰亚胺降解决定子体 |
CN107629057B (zh) * | 2016-07-19 | 2020-03-27 | 上海勋和医药科技有限公司 | Bet蛋白抑制剂及其应用 |
BR112019008435A2 (pt) | 2016-12-16 | 2019-07-09 | Hoffmann La Roche | processos para a preparação de um composto de fórmula, processo para a fabricação de um composto de fórmula, processos para a purificação de um composto de fórmula, composto e presente invenção |
BR112020025003A2 (pt) | 2018-06-13 | 2021-03-23 | Dybly Ag | preparação de derivados de triazepina condensados e uso dos mesmos como inibidores de bet |
CN114702451B (zh) * | 2022-03-29 | 2024-05-14 | 国药集团国瑞药业有限公司 | 一种氯硝西泮及其中间体的制备方法 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3239364B2 (ja) * | 1991-10-11 | 2001-12-17 | ウェルファイド株式会社 | 骨粗鬆症治療薬およびジアゼピン化合物 |
EP0661284A1 (en) * | 1992-09-18 | 1995-07-05 | Yoshitomi Pharmaceutical Industries, Ltd. | Thienodiazepine compound and medicinal use thereof |
BRPI0817537B1 (pt) | 2007-10-17 | 2022-04-05 | Kudos Pharmaceuticals Limited | 4-[3-(4-ciclopropanocarbonil-piperazina-1-carbonil)-4-fluoro-benzil]-2h-ftalazin-1-ona, método para obtê-lo, composição farmacêutica compreendendo o mesmo, bem como usos terapêuticos do dito composto |
US8476260B2 (en) * | 2007-12-28 | 2013-07-02 | Mitsubishi Tanabe Pharma Corporation | Antitumor agent |
PT2722334E (pt) | 2009-11-05 | 2016-03-11 | Glaxosmithkline Llc | Inibidor do bromodomínio da benzodiazepina |
DK2496582T3 (en) * | 2009-11-05 | 2016-03-21 | Glaxosmithkline Llc | Benzodiazepine-BROMDOMAeNEINHIBITOR. |
GB0919426D0 (en) * | 2009-11-05 | 2009-12-23 | Glaxosmithkline Llc | Novel compounds |
CN103119160B (zh) | 2010-05-14 | 2016-06-01 | 达那-法伯癌症研究所 | 用于调节代谢的组合物和方法 |
EP2571503B1 (en) | 2010-05-14 | 2015-01-07 | Dana-Farber Cancer Institute, Inc. | Compositions and their use in treating neoplasia, inflammatory disease and other disorders |
AR084070A1 (es) * | 2010-12-02 | 2013-04-17 | Constellation Pharmaceuticals Inc | Inhibidores del bromodominio y usos de los mismos |
WO2013033268A2 (en) * | 2011-08-29 | 2013-03-07 | Coferon, Inc. | Bivalent bromodomain ligands, and methods of using same |
-
2015
- 2015-04-08 DK DK15776821.9T patent/DK3129378T3/da active
- 2015-04-08 ES ES15776821T patent/ES2751642T3/es active Active
- 2015-04-08 US US15/129,657 patent/US9884874B2/en active Active
- 2015-04-08 JP JP2016561662A patent/JP6333996B2/ja active Active
- 2015-04-08 KR KR1020167030835A patent/KR101928521B1/ko active IP Right Grant
- 2015-04-08 CN CN201580016461.0A patent/CN106132968B/zh active Active
- 2015-04-08 EP EP15776821.9A patent/EP3129378B1/en active Active
- 2015-04-08 PL PL15776821T patent/PL3129378T3/pl unknown
- 2015-04-08 WO PCT/KR2015/003530 patent/WO2015156601A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
JP2017510605A (ja) | 2017-04-13 |
KR20160133006A (ko) | 2016-11-21 |
EP3129378A1 (en) | 2017-02-15 |
CN106132968B (zh) | 2019-04-05 |
DK3129378T3 (da) | 2019-10-07 |
US9884874B2 (en) | 2018-02-06 |
JP6333996B2 (ja) | 2018-05-30 |
ES2751642T3 (es) | 2020-04-01 |
CN106132968A (zh) | 2016-11-16 |
WO2015156601A1 (en) | 2015-10-15 |
KR101928521B1 (ko) | 2018-12-13 |
US20170174702A1 (en) | 2017-06-22 |
EP3129378B1 (en) | 2019-06-26 |
EP3129378A4 (en) | 2017-08-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL3431105T3 (pl) | Kompozycja lecznicza do leczenia raka | |
HK1249103B (zh) | 多環氨甲醯基吡啶酮化合物及其藥物用途 | |
IL249231A0 (en) | Pharmaceutical combinations for cancer treatment | |
SI3377516T1 (sl) | Sestavek za zdravljenje raka | |
ZA201900052B (en) | Pharmaceutical combinations for treating cancer | |
PL3129378T3 (pl) | Związki hamujące bromodomenę i zawierająca je kompozycja farmaceutyczna do zapobiegania lub leczenia nowotworu | |
PL3130353T3 (pl) | Kompozycja farmaceutyczna na bazie nanostruktury grafenu do zapobiegania lub leczenia chorób neurodegeneracyjnych | |
IL268416A (en) | Pharmaceutical combinations for cancer treatment | |
HK1232128A1 (zh) | 用於預防或治療皮疹的藥物組合物 | |
EP3020399A4 (en) | PHARMACEUTICAL COMPOSITION FOR THE PREVENTION AND TREATMENT OF CANCER | |
PT3290051T (pt) | Composição farmacêutica para o tratamento e/ou prevenção de cancro | |
ZA201802268B (en) | Methods and compositions for preventing or treating cancer | |
ZA201707024B (en) | Cancer treatment composition | |
IL252493A0 (en) | Compounds for use in the prevention or treatment of cancer | |
HUE051563T2 (hu) | Gyógyszerkészítmény rák megelõzésére vagy kezelésére | |
EP3372233A4 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND / OR PREVENTION OF CANCER | |
EP3388067A4 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OR PREVENTION OF CANCER | |
AP2016009066A0 (en) | A drug for treating cancer |